October 18, 2007 - Lucid Inc.’s VivaNet telemedicine server and its VivaScope confocal imagers, which relies on using special microscopes to digitally image a patient’s skin, may bypass the need to surgically biopsy many patients.
The cellular resolution images may then be used by physicians to assist in forming a clinical judgment for a variety of skin conditions, including, for example, melanoma, basal cell carcinoma, actinic keratoses, and contact dermatitis.
A typical VivaScope imaging session produces two types of images of the patient’s skin: dermatoscopic-quality, full-color macroscopic pictures, and microscopic, cellular resolution images. Like a routine biopsy, the images can then be read by a dermatologist or a pathologist and the diagnosis presented to the patient.
For more information: www.lucid-tech.com.
Related Content
News | Breast Biopsy Systems
July 7, 2021 — GE Healthcare announced the installation of Serena Bright in five hospitals and radiology centers around ...
July 07, 2021 
News | Breast Imaging
January 4, 2021 — Hologic, Inc. announced it has completed the acquisition of SOMATEX Medical Technologies GmbH, a ...
January 04, 2021 
News | Prostate Cancer
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their lifetime. It’s both the second most common cancer and second most common cause of cancer death in American men. Early detection is critical and can increase a man’s chances of survival.
August 20, 2019 News | Biopsy Systems
Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy device which leverages the real-time tissue characterization capability of its radiofrequency (RF) spectroscopy technology.
March 29, 2019 
Technology | Interventional Radiology
The U.S. Food and Drug Administration (FDA) cleared the Ion endoluminal system from Intuitive Surgical Inc. to enable minimally invasive biopsy in the peripheral lung.
February 20, 2019 
News | Prostate Cancer
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two companies work to improve the way prostate cancer is visualized and detected. Cambridge Consultants is applying deep learning to high-resolution micro-ultrasound imaging to identify potential suspicious regions of tissue and inform urologists who may want to consider this additional data in their biopsy protocol. Early results show real promise, according to the companies.
February 12, 2019 
News | Breast Biopsy Systems
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce unnecessary breast biopsies, according to a new study appearing in the journal Radiology
January 17, 2019 
Videos | Radiation Oncology
Aadel Chaudhuri, M.D., assistant professor of radiation oncology, Washington University, St. Louis, Mo., explains his ...
November 07, 2018 
News | Radiation Oncology
October 30, 2018 — A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to ...
October 30, 2018 
Technology | Breast Biopsy Systems
Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system for breast tissue biopsies.
October 03, 2018 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now